In the development and manufacturing of biologics, rigorous particle analysis is critical for patient safety. However, conventional methods like Light Obscuration (LO) or standard Micro-Flow Imaging (MFI) face two major limitations. First, they struggle to accurately differentiate among protein aggregates, silicone oil droplets, and glass particles. Second, the strict focusing requirements of standard MFI fundamentally limit sample throughput, creating severe bottlenecks in high-demand manufacturing environments.
HoloPharm redefines quality control by bringing high-fidelity holographic imaging and AI directly to the analytical workflow. Utilizing coherent light holography, HoloPharm captures a massive depth of field. This eliminates the narrow focus constraints of conventional microscopy, enabling the rapid, high-throughput analysis of large sample volumes without sacrificing image clarity.
By capturing both high-resolution morphological data and optical refractive index changes, our proprietary AI models can precisely classify particle types within liquid injectable drugs. HoloPharm empowers pharmaceutical researchers and QC engineers to confidently distinguish between protein aggregates, silicone oil, and contaminants, ensuring the highest standards of drug efficacy and patient safety.